SCHEMBL6598260

SCHEMBL6598260

CC(C)(C)[Si](C)(CCc1ccc(N)cc1)O[Si](C)(CCc1ccc(N)cc1)C(C)(C)C

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GFER P55789 2/20 0.45
CYP19A1 P11511 5/20 0.40
MAOB P27338 4/20 0.39
MAOA P21397 2/20 0.39
ESRRG P62508 1/20 0.38
ALDH1A1 P00352 1/20 0.35
CYP3A4 P08684 1/20 0.35
TSHR P16473 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
LOXL2 Q9Y4K0 1/20 0.34
RECQL P46063 1/20 0.34
NPC1 O15118 1/20 0.34
TP53 P04637 1/20 0.34
MAPT P10636 1/20 0.34
HTT P42858 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
GRK6 P43250 1/20 0.34
EPHX2 P34913 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2809807 0.82 TAAR1 (0.40) EPHX2
SCHEMBL3847130 0.80 MAOB (0.47) CYP19A1MAOBMAOACYP3A4TP53
SCHEMBL16424873 0.79 GFER (0.50) GFERCYP19A1MAOBMAOAESRRG
SCHEMBL26185016 0.77 GFER (0.52) GFERCYP19A1MAOBMAOAALDH1A1
SCHEMBL7337667 0.76 MAOB (0.35) GFERCYP19A1MAOBMAOAALDH1A1
SCHEMBL8954118 0.76 GFER (0.50) GFERCYP19A1MAOBMAOAALDH1A1
SCHEMBL3211356 0.74 GFER (0.59) GFERCYP19A1MAOBMAOAALDH1A1
SCHEMBL6212378 0.73 WNT3A (0.34)
SCHEMBL3843065 0.72 SIGMAR1 (0.33) ALDH1A1
SCHEMBL8953980 0.72 GFER (0.50) GFERCYP19A1MAOBMAOAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1156037-B1 CHONDRONGENESIS PROMOTORS AND INDOLIN-2-ONE DERIVATIVES CHUGAI PHARMACEUTICAL CO LTD (JP) 2004-12-01 EP disclosed
US-6716628-B2 CARTILAGE REPAIR AGENTS CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2004-04-06 US disclosed
US-20030187054-A1 Preparations for chondrogenesis CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-10-02 US disclosed
US-20030119896-A1 Chondrogenesis promoters and indolin-2-one derivatives CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-06-26 US disclosed
US-6500854-B1 CHONDROCYTE PROLIFERATORS SUCH AS 1-(2,2-DIETHOXYETHYL)-3-(N'-(4-HYDROXYMETHYLPHENYL)UREIDO)-3-((4 -METHYLPHENYL)AMINO-CARBONYLMETHYL)INDOLIN-2-ONE FOR PROPHYLAXIS BONE DISORDERS CHUGAI SEI YAKU KABUSHIKI KAISHA (JP) 2002-12-31 US disclosed
EP-1266664-A1 PREPARATIONS FOR CHONDROGENESIS CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2002-12-18 EP disclosed
EP-1156037-A1 CHONDRONGENESIS PROMOTORS AND INDOLIN-2-ONE DERIVATIVES CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2001-11-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030187054-A1 Preparations for chondrogenesis COL2A1, BMP2, COL1A1 GFER 4556/4885CYP19A1 1147/4885MAOB 3469/4885
US-20030119896-A1 Chondrogenesis promoters and indolin-2-one derivatives SOX18, BMP2, EBP GFER 4301/4885CYP19A1 341/4885MAOB 1132/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.